AbbVie (ABBV.BA) has a profit margin of 15.74%, below the Healthcare sector average of 17.63%.
Get informed when a big investor buys or sells
+ FollowAs of Sep 2026
Trailing 12 months ending Sep 2026
AbbVie (ABBV.BA) currently reports a profit margin of 15.74% as of September 2026. That compares with 4.0% in the prior-year period — up 293.1% year over year. That is below the Healthcare sector average of 17.63%. Use the charts on this page to explore AbbVie's profit margin history and peer comparisons.
AbbVie's profit margin increased from 4.0% to 15.74% — a 293.1% year-over-year increase (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
AbbVie's profit margin of 15.74% is lower than the Healthcare sector average of 17.63%. That is roughly 10.7% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' profit margin, but AbbVie's current 15.74% should be judged against Healthcare norms (sector average: 17.63%) and against ABBV.BA's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current profit margin of 15.74%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 17.63%. From there, open related valuation or income-statement pages for AbbVie, and consider following ABBV.BA for alerts when major investors trade the stock.